Clinical Trial Update: Efficacy and Safety of Odevixibat in Children With Biliary Atresia Who Have Undergone a Kasai HPE (BOLD) [Phase 3]

View source ↗

Summary

Phase 3 trial update on the efficacy and safety of odevixibat in children with biliary atresia post-Kasai procedure (BOLD study).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Atresia

Drugs mentioned

• Odevixibat (odevixibat)

Snippet

Sponsor: Albireo, an Ipsen Company | Conditions: Biliary Atresia | Phase 3 | Status: COMPLETED